Skip to main content
. 2017 Oct 9;50(6):e12395. doi: 10.1111/cpr.12395

Figure 7.

Figure 7

3‐Brpa or rapamycin reduces the tumour burden of prostate cancer cells in nude mice. (A and B) LNCaP cells with lowly expressed lincRNA‐p21 were inoculated into nude mice. Three weeks after injection, the mice bearing tumour were treated with placebo (Con) or rapamycin (Rapa) n = 8. (A) Tumour volume was calculated. (B) Representative photograph of tumours. (C and D) LNCaP cells with lowly expressed lincRNA‐p21 were inoculated into nude mice. 3 weeks after injection, the mice bearing tumour were treated with placebo (Con) or 3‐Brpa (Rapa) n = 8. (A) Tumour volume was calculated. (B) Representative photograph of tumours. (E and F) Tumour tissues described in (A) and (C) were subjected to Western blot. *P< .05; **P< .01; ***P< .001; ****P< .0001